Stay updated on CAB-AXL-ADC in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.

Latest updates to the CAB-AXL-ADC in Sarcoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check33 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
- Check48 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check62 days agoChange DetectedThe CAB-AXL-ADC Safety and Efficacy Study has been updated with a new estimated last update date of January 13, 2025, while the previous version has been removed, indicating a shift in the study's timeline and possibly its status.SummaryDifference20%
- Check69 days agoChange DetectedThe website has updated its contact information for several principal investigators and added new contacts, while also removing previous entries, indicating a significant refresh in personnel details.SummaryDifference30%
- Check99 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
Stay in the know with updates to CAB-AXL-ADC in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.